Duke University Eye Center
Durham, North Carolina, 27705, United States
Location contact
Agnes C Owete, MD
SUB_INVESTIGATOR
Jonathan Shepherd
CONTACT
Leon W Herndon, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07803536
This is a research study to find out if removing the ripcord from a glaucoma drainage device more than 3 months after it has been placed has any effect on intraocular pressure. Participation in research studies is voluntary.
The ripcord will be removed at a routine glaucoma care visit and intraocular pressure will be measured before removal, 30 minutes following, and at 1 week, 6 weeks and 3-month intervals during regular clinic visits.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Durham, North Carolina, 27705, United States
Agnes C Owete, MD
SUB_INVESTIGATOR
Jonathan Shepherd
CONTACT
Leon W Herndon, MD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients who have had a ripcord in place for greater than 3 months postoperatively will undergo ripcord removal in the office.
Time frame: Immediately after, 1 week, 6 weeks and 3-month intervals
Change in intraocular pressure
Time frame: 1 week, 6 week and 3 month interval
Measured by the number of participants who miss drop doses
Contact information is provided by the study sponsor or research team.
Duke University
Other
Prospective, Single-arm Interventional Study to Determine Effect of Late Ripcord Removal From Glaucoma Drainage Device
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07780916
Eye Diseases, GLAUCOMA 1, OPEN ANGLE, D (Disorder)
Würzburg, Bavaria, Germany
View Trial DetailsNCT06689696
Eye Diseases, GLAUCOMA 1, OPEN ANGLE, D (Disorder)
Fullerton, California, United States
View Trial DetailsNCT07765147
Eye Diseases, GLAUCOMA 1, OPEN ANGLE, D (Disorder)
Indianapolis, Indiana, United States
View Trial DetailsNCT07359547
Eye Diseases, GLAUCOMA 1, OPEN ANGLE, D (Disorder)
Leuven, Vlaams-brabant, Belgium
View Trial Details